COVID-19 free pathways decrease postoperative complications in patients undergoing elective colorectal surgery.
COVID-free
Covid surgery
Surgical complication
Journal
Surgery in practice and science
ISSN: 2666-2620
Titre abrégé: Surg Pract Sci
Pays: England
ID NLM: 9918402387206676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
31
08
2022
accepted:
01
09
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
4
10
2022
Statut:
ppublish
Résumé
To reduce the exposition risk to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in surgical patients more prone to develop serious forms of Coronavirus disease 2019, a reorganization that previewed the creation "COVID-19-free" hospitals or units was pursued. The aim of this study was to quantify the effect of clear pathways to reduce the risk of SARS-Cov-2 transmission, on postoperative complications. Data of all consecutive patients undergoing surgical procedure for colorectal diseases, between November 2019 and July 2020 in two Italian referral centers, were retrospectively analyzed. Patients were divided into two groups: the ones underwent surgical procedures during the period before the pandemic from November 2019 to March 2020 (Group 1) (before-COVID), and those who underwent surgical procedure from April to July 2020 during the pandemic (Group 2) (during-COVID pandemic). Overall, 264 patients were collected, 168 (63.4%) in Group 1 and 96 (36.4%) Group 2. Preoperative characteristics were similar between groups; during the pandemic there was a higher proportion of patients who underwent surgical procedures for malignancy compared with the period before the pandemic (92.7% vs 72%; In this cohort study COVID-19-free pathways were significantly associated with low rate of postoperative morbidity in patients undergoing colorectal elective surgery.
Sections du résumé
Background
UNASSIGNED
To reduce the exposition risk to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in surgical patients more prone to develop serious forms of Coronavirus disease 2019, a reorganization that previewed the creation "COVID-19-free" hospitals or units was pursued. The aim of this study was to quantify the effect of clear pathways to reduce the risk of SARS-Cov-2 transmission, on postoperative complications.
Methods
UNASSIGNED
Data of all consecutive patients undergoing surgical procedure for colorectal diseases, between November 2019 and July 2020 in two Italian referral centers, were retrospectively analyzed. Patients were divided into two groups: the ones underwent surgical procedures during the period before the pandemic from November 2019 to March 2020 (Group 1) (before-COVID), and those who underwent surgical procedure from April to July 2020 during the pandemic (Group 2) (during-COVID pandemic).
Results
UNASSIGNED
Overall, 264 patients were collected, 168 (63.4%) in Group 1 and 96 (36.4%) Group 2. Preoperative characteristics were similar between groups; during the pandemic there was a higher proportion of patients who underwent surgical procedures for malignancy compared with the period before the pandemic (92.7% vs 72%;
Conclusion
UNASSIGNED
In this cohort study COVID-19-free pathways were significantly associated with low rate of postoperative morbidity in patients undergoing colorectal elective surgery.
Identifiants
pubmed: 36185398
doi: 10.1016/j.sipas.2022.100125
pii: S2666-2620(22)00067-5
pmc: PMC9434910
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100125Informations de copyright
© 2022 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
All authors declare that there was no conflict of interest.
Références
Int J Surg. 2020 Aug;80:157-161
pubmed: 32679205
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Eur J Neurol. 2020 Nov;27(11):2348-2360
pubmed: 32668062
Am J Emerg Med. 2020 Sep;38(9):1715-1721
pubmed: 32731141
J Clin Oncol. 2021 Jan 1;39(1):66-78
pubmed: 33021869
Surg Endosc. 2020 Jun;34(6):2327-2331
pubmed: 32323016
J Am Heart Assoc. 2020 Jul 7;9(13):e016793
pubmed: 32393136
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Lancet Oncol. 2013 Mar;14(3):210-8
pubmed: 23395398
Ann Surg. 2018 Jun;267(6):1034-1046
pubmed: 28984644
Int J Surg. 2020 Jun;78:5-6
pubmed: 32302745
Surgery. 2020 Oct;168(4):572-577
pubmed: 32739140
Surgery. 2020 Jul;168(1):4-10
pubmed: 32451162
Patient Saf Surg. 2020 Oct 12;14:37
pubmed: 33062056
Int J Surg. 2020 Oct;82:231-239
pubmed: 32877754
Int J Surg. 2020 Aug;80:194-201
pubmed: 32693151
Am J Infect Control. 2020 Apr;48(4):386-390
pubmed: 32093979
Updates Surg. 2021 Feb;73(1):321-329
pubmed: 33184782
J Am Coll Surg. 2012 Aug;215(2):193-200
pubmed: 22632912
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Surgery. 2021 Feb;169(2):264-274
pubmed: 33158548
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Expert Rev Gastroenterol Hepatol. 2021 Jan;15(1):41-50
pubmed: 32955375
Eur J Surg Oncol. 2020 Jun;46(6):1186-1187
pubmed: 32336627
JAMA Surg. 2020 Aug 1;155(8):691-702
pubmed: 32530453